Caterina Alati
- Hematology top 5%
- Acute Myeloid Leukemia Research 13
- Multiple Myeloma Research and Treatments 5
- Chronic Myeloid Leukemia Treatments 4
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Virus-based gene therapy research 3
-
- CAR-T cell therapy research 9
-
- Acute Lymphoblastic Leukemia research 4
-
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Francesca RoncoMassimo MartinoEsther Natalie OlívaFrancesco NobileGiovanni MartinelliClaudio CerchioneGerardo MusuracaAntonio Marino
- Cited by
- HematologyGeneticsOncology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (8 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ItalyGermanyUnited Kingdom
In The Last Decade
Caterina Alati
23 papers receiving 309 citations
Peers
Comparison fields: 5 of 32
- Hematology 209
- Genetics 107
- Oncology 114
- Immunology 30
- Emergency Medicine 13
Countries citing papers authored by Caterina Alati
This map shows the geographic impact of Caterina Alati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Alati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Alati more than expected).
Fields of papers citing papers by Caterina Alati
This network shows the impact of papers produced by Caterina Alati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Alati. The network helps show where Caterina Alati may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caterina Alati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2021 | 70 | |
| 13 | 2021 | 23 | |
| 14 | 2016 | 1 | |
| 15 | 2015 | 15 | |
| 16 | 2014 | 6 | |
| 17 | 2014 | 3 | |
| 18 | 2013 | 12 | |
| 19 | 2010 | 60 | |
| 20 | 2010 | 30 |
About Caterina Alati
Caterina Alati is a scholar working on Hematology, Genetics and Oncology, having authored 29 papers that have together received 313 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), CAR-T cell therapy research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Virus-based gene therapy research (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Hematology (209 citations), Genetics (107 citations) and Oncology (114 citations). Caterina Alati has collaborated with scholars based in Italy, Germany and United Kingdom. Frequent co-authors include Francesca Ronco, Massimo Martino, Esther Natalie Olíva, Francesco Nobile, Giovanni Martinelli, Claudio Cerchione, Gerardo Musuraca, Antonio Marino, Giulia Praticò and Iolanda Donatella Vincelli. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.